Related Experiment Video
Updated: May 3, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Biomarkers and response to bevacizumab--response
Fiona Collinson1, Michelle Hutchinson, Rachel A Craven
1Authors' Affiliations: Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds; St James's Institute of Oncology, Bexley Wing; Cancer Research UK Centre, Leeds Institute of Molecular Medicine, St James's University Hospital; Department of Clinical Biochemistry and Immunology, Leeds General Infirmary, Leeds; MRC Clinical Trials Unit; UCL Cancer Institute, University College, London; and Christie Hospital, University of Manchester, Withington, Manchester, United Kingdom.
No abstract available in PubMed .

